Equity Plans

3 Months Ended

Dec. 01, 2022

Share-Based Payment Arrangement [Abstract]

Equity Plans

Equity Plans

As of December 1, 2022, 51 million shares of our common stock were available for future awards under our equity plans, including 18 million shares approved for issuance under our employee stock purchase plan (“ESPP”).

Restricted Stock and Restricted Stock Units (“Restricted Stock Awards”)

Restricted Stock Awards activity is summarized as follows:

Three months ended	December 1, 2022		December 2, 2021
Restricted stock award shares granted	14		10
Weighted-average grant-date fair value per share	$	53.94	$	70.42

Stock-based Compensation Expense

Stock-based compensation expense recognized in our statements of operations is presented below. Stock-based compensation expense of $69 million and $48 million was capitalized and remained in inventory as of December 1, 2022 and September 1, 2022, respectively.

Three months ended	December 1, 2022		December 2, 2021
Stock-based compensation expense by caption
Research and development	$	53	$	38
Selling, general, and administrative	37		35
Cost of goods sold	36		43
Restructure	—		(5)
	$	126	$	111
Stock-based compensation expense by type of award
Restricted stock awards	$	109	$	96
ESPP	17		14
Stock options	—		1
	$	126	$	111

As of December 1, 2022, $1.59 billion of total unrecognized compensation costs for unvested awards, before the effect of any future forfeitures, was expected to be recognized through the first quarter of 2027, resulting in a weighted-average period of 1.5 years.